LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 4821 | 11103 | 0.4342 | 0.4702 |
MCF 10A | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 4073 | 11103 | 0.3668 | 0.3813 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 3347 | 11103 | 0.3014 | 0.2853 |
MCF 10A | PD184352 | 10 | uM | LJP5 | 72 | hr | 1694 | 3034 | 11103 | 0.2733 | 0.2397 |
MCF 10A | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11201 | 11103 | 1.0088 | 1.0065 |
MCF 10A | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11028 | 11103 | 0.9933 | 0.9949 |
MCF 10A | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10909 | 11103 | 0.9827 | 0.9870 |
MCF 10A | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 11583 | 11103 | 1.0433 | 1.0314 |
MCF 10A | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 12034 | 11103 | 1.0839 | 1.0602 |
MCF 10A | PLX-4720 | 10 | uM | LJP5 | 72 | hr | 1694 | 10314 | 11103 | 0.9289 | 0.9457 |
MCF 10A | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10844 | 11217 | 0.9667 | 0.9753 |
MCF 10A | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10440 | 11217 | 0.9308 | 0.9481 |
MCF 10A | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 10095 | 11217 | 0.9001 | 0.9243 |
MCF 10A | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 9605 | 11217 | 0.8563 | 0.8894 |
MCF 10A | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 8365 | 11217 | 0.7457 | 0.7959 |
MCF 10A | Lapatinib | 10 | uM | LJP6 | 72 | hr | 1694 | 4508 | 11217 | 0.4018 | 0.4314 |
MCF 10A | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1694 | 12244 | 11217 | 1.0916 | 1.0653 |
MCF 10A | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1694 | 12338 | 11217 | 1.0999 | 1.0710 |
MCF 10A | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1694 | 12534 | 11217 | 1.1174 | 1.0831 |
MCF 10A | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 1694 | 12479 | 11217 | 1.1126 | 1.0798 |
MCF 10A | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 1694 | 12704 | 11217 | 1.1326 | 1.0934 |
MCF 10A | Sirolimus | 10 | uM | LJP6 | 72 | hr | 1694 | 12441 | 11217 | 1.1091 | 1.0774 |
MCF 10A | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10958 | 11217 | 0.9768 | 0.9828 |
MCF 10A | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9950 | 11217 | 0.8870 | 0.9138 |
MCF 10A | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 8257 | 11217 | 0.7361 | 0.7874 |